GAS5 has been reported to function as a tumor suppressor-like gene, that can block ovary cancer progression [18–20], whereas UCA1 serves as a potential novel biomarker and therapeutic target for ovarian cancer [21, 22]. This evidence concerns the gene UCA1 and ovarian cancer.